GE HealthCare Technologies Inc.

GEHC Nasdaq SEC CIK 1932393
Follow GE HealthCare Technologies Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $5.5B +7.2% vs same quarter last year
Net income $615M +37.9% vs same quarter last year
EPS, diluted $1.36 +38.8% vs same quarter last year
Operating cash flow $907M +53% vs same quarter last year
Revenue by quarter
$5.3B
$4.8B
$5B
$5.1B
$5.7B
$5.1B
$5.3B
$5.5B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
$0$10B$20B$30BFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$20.6B$2.1B
FY24$19.7B$2B
FY23$19.6B$1.6B
FY22$18.3B$1.9B
FY21$17.6B$2.2B
FY20--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2540%13.4%10.1%
FY2441.7%13.3%10.1%
FY2340.5%12.5%8%
FY2239.1%13.8%10.4%
FY2140.8%15.9%12.8%
FY20---
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5B$2BFY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$1.5B
FY24$1.6B
FY23$1.7B
FY22$1.8B
FY21$1.4B
FY20-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300MFY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25$64M$200M
FY24$55M$0
FY23$41M$0
FY22$0-
FY21$0-
FY20--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • GE HealthCare Technologies
  • Healthcare median
−100%−75%−50%−25%0%25%FY20FY21FY22FY23FY24FY25
Show the numbers
YearGE HealthCare TechnologiesHealthcare median
FY2510.1%−30.6%
FY2410.1%−47%
FY238%−58%
FY2210.4%−80.4%
FY2112.8%−71.9%
FY20-−62.2%